- Silver struggles to capitalize on its modest intraday gains to the $21.00 neighbourhood.
- The technical set-up favours bulls and supports prospects for some meaningful upside.
- Dips towards the 100 DMA could be seen as a buying opportunity and remain limited.
Silver builds on the previous day's goodish bounce from sub-$20.00 levels and edges higher during the first half of trading on Thursday. The uptick, however, falters ahead of the $21.00 round figure during the early European session, forcing spot prices to surrender modest intraday gains.
From a technical perspective, this week's sustained breakout through a nearly four-month-old descending trend-line resistance and the 100-day SMA favours bullish traders. The positive outlook is reinforced by bullish technical indicators on the daily chart, which are still far from being in the overbought territory.
That said, it will still be prudent to wait for a move back above the $21.00 mark before positioning for any further appreciating move. The XAG/USD might then aim to test the very important 200-day SMA, around the $21.90 area. Some follow-through buying beyond the $22.00 level should pave the way for further gains.
The XAG/USD could then accelerate the momentum and climb towards the next relevant resistance near the $22.40 region. The subsequent move up has the potential to lift spot prices towards the $23.00 round-figure mark.
On the flip side, the $20.00 psychological mark, or the 100-day SMA, now seems to have emerged as immediate strong support. This is followed by the descending trend-line resistance breakout point, around the $19.55 region. The latter coincides with the 50-day SMA and should now act as a strong base for the XAG/USD.
Silver daily chart
Key levels to watch
|Today last price||20.69|
|Today Daily Change||0.05|
|Today Daily Change %||0.24|
|Today daily open||20.64|
|Previous Daily High||21.07|
|Previous Daily Low||19.94|
|Previous Weekly High||19.29|
|Previous Weekly Low||17.97|
|Previous Monthly High||20.02|
|Previous Monthly Low||17.56|
|Daily Fibonacci 38.2%||20.37|
|Daily Fibonacci 61.8%||20.64|
|Daily Pivot Point S1||20.03|
|Daily Pivot Point S2||19.42|
|Daily Pivot Point S3||18.9|
|Daily Pivot Point R1||21.16|
|Daily Pivot Point R2||21.68|
|Daily Pivot Point R3||22.29|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.